456 related articles for article (PubMed ID: 32849612)
1. Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis.
Lasola JJM; Kamdem H; McDaniel MW; Pearson RM
Front Immunol; 2020; 11():1726. PubMed ID: 32849612
[TBL] [Abstract][Full Text] [Related]
2. Cargo-less nanoparticles program innate immune cell responses to toll-like receptor activation.
Casey LM; Kakade S; Decker JT; Rose JA; Deans K; Shea LD; Pearson RM
Biomaterials; 2019 Oct; 218():119333. PubMed ID: 31301576
[TBL] [Abstract][Full Text] [Related]
3. Current trends in inflammatory and immunomodulatory mediators in sepsis.
Aziz M; Jacob A; Yang WL; Matsuda A; Wang P
J Leukoc Biol; 2013 Mar; 93(3):329-42. PubMed ID: 23136259
[TBL] [Abstract][Full Text] [Related]
4. Role of dendritic cells in the host response to biomaterials and their signaling pathways.
Zhu FJ; Tong YL; Sheng ZY; Yao YM
Acta Biomater; 2019 Aug; 94():132-144. PubMed ID: 31108257
[TBL] [Abstract][Full Text] [Related]
5. The inflammasome in host response to biomaterials: Bridging inflammation and tissue regeneration.
Vasconcelos DP; Águas AP; Barbosa MA; Pelegrín P; Barbosa JN
Acta Biomater; 2019 Jan; 83():1-12. PubMed ID: 30273748
[TBL] [Abstract][Full Text] [Related]
6. Control of innate immune response by biomaterial surface topography, energy, and stiffness.
Abaricia JO; Farzad N; Heath TJ; Simmons J; Morandini L; Olivares-Navarrete R
Acta Biomater; 2021 Oct; 133():58-73. PubMed ID: 33882355
[TBL] [Abstract][Full Text] [Related]
7. Biomaterial mediated immunomodulation: An interplay of material environment interaction for ameliorating wound regeneration.
Dixit K; Bora H; Lakshmi Parimi J; Mukherjee G; Dhara S
J Biomater Appl; 2023 Apr; 37(9):1509-1528. PubMed ID: 37069479
[TBL] [Abstract][Full Text] [Related]
8. T lymphocytes as critical mediators in tissue regeneration, fibrosis, and the foreign body response.
Adusei KM; Ngo TB; Sadtler K
Acta Biomater; 2021 Oct; 133():17-33. PubMed ID: 33905946
[TBL] [Abstract][Full Text] [Related]
9. Engineering vaccines and niches for immune modulation.
Purwada A; Roy K; Singh A
Acta Biomater; 2014 Apr; 10(4):1728-40. PubMed ID: 24373907
[TBL] [Abstract][Full Text] [Related]
10. Biomaterial mediated simultaneous delivery of spermine and alpha ketoglutarate modulate metabolism and innate immune cell phenotype in sepsis mouse models.
Inamdar S; Tylek T; Thumsi A; Suresh AP; Jaggarapu MMCS; Halim M; Mantri S; Esrafili A; Ng ND; Schmitzer E; Lintecum K; de Ávila C; Fryer JD; Xu Y; Spiller KL; Acharya AP
Biomaterials; 2023 Feb; 293():121973. PubMed ID: 36549041
[TBL] [Abstract][Full Text] [Related]
11. Advanced Immunomodulatory Biomaterials for Therapeutic Applications.
Park JE; Kim DH
Adv Healthc Mater; 2024 May; ():e2304496. PubMed ID: 38716543
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury.
Kumar V
Front Immunol; 2020; 11():1722. PubMed ID: 32849610
[TBL] [Abstract][Full Text] [Related]
13. Biomaterials for nanoparticle vaccine delivery systems.
Sahdev P; Ochyl LJ; Moon JJ
Pharm Res; 2014 Oct; 31(10):2563-82. PubMed ID: 24848341
[TBL] [Abstract][Full Text] [Related]
14. Immuno-modulatory biomaterials as anti-inflammatory therapeutics.
Lynch RI; Lavelle EC
Biochem Pharmacol; 2022 Mar; 197():114890. PubMed ID: 34990595
[TBL] [Abstract][Full Text] [Related]
15. Biomaterials as Local Niches for Immunomodulation.
Adu-Berchie K; Mooney DJ
Acc Chem Res; 2020 Sep; 53(9):1749-1760. PubMed ID: 32786230
[TBL] [Abstract][Full Text] [Related]
16. Cell-Inspired Biomaterials for Modulating Inflammation.
Bender EC; Kraynak CA; Huang W; Suggs LJ
Tissue Eng Part B Rev; 2022 Apr; 28(2):279-294. PubMed ID: 33528306
[TBL] [Abstract][Full Text] [Related]
17. Harnessing biomaterial architecture to drive anticancer innate immunity.
Davis MA; Cho E; Teplensky MH
J Mater Chem B; 2023 Nov; 11(46):10982-11005. PubMed ID: 37955201
[TBL] [Abstract][Full Text] [Related]
18. Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance.
Andorko JI; Hess KL; Jewell CM
AAPS J; 2015 Mar; 17(2):323-38. PubMed ID: 25533221
[TBL] [Abstract][Full Text] [Related]
19. Tissue-Targeted Drug Delivery Strategies to Promote Antigen-Specific Immune Tolerance.
Rui Y; Eppler HB; Yanes AA; Jewell CM
Adv Healthc Mater; 2023 Jan; 12(6):e2202238. PubMed ID: 36417578
[TBL] [Abstract][Full Text] [Related]
20. Mast cells as effector cells of innate immunity and regulators of adaptive immunity.
Cardamone C; Parente R; Feo GD; Triggiani M
Immunol Lett; 2016 Oct; 178():10-4. PubMed ID: 27393494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
